Dr Gordon on the FDA Approval of Liso-Cel in Relapsed/Refractory MCL
Leo I. Gordon, MD, Abby and John Friend Professor of Oncology Research, professor, medicine (hematology and oncology), Feinberg School of Medicine, Robert H. Lurie Cancer Center, discusses the significance of the FDA approval of lisocabtagene maraleucel ( …